US Stock MarketDetailed Quotes

GLUE Monte Rosa Therapeutics

Watchlist
  • 4.790
  • 0.0000.00%
Trading Apr 30 11:01 ET
294.63MMarket Cap-4.89P/E (TTM)

About Monte Rosa Therapeutics Company

Monte Rosa Therapeutics, Inc. operates as a biotechnology company focused on developing precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.

Company Profile

SymbolGLUE
Company NameMonte Rosa Therapeutics
Listing DateJun 24, 2021
Issue Price19.00
Founded2019
CEODr. Markus Warmuth, M.D.
MarketNASDAQ
Employees134
Fiscal Year Ends12-31
Address321 Harrison Avenue,Suite 900
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02118
Phone1-617-949-2643

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Markus Warmuth, M.D.
  • Director, Chief Executive Officer, Principal Financial Officer and President
  • 2.44M
  • Jennifer Champoux
  • Chief Operating Officer
  • --
  • Dr. Sharon Townson, PhD
  • Chief Scientific Officer
  • --
  • Dr. Philip Nickson, J.D.,PhD
  • Chief Business and Legal Officer
  • 1.29M
  • Dr. Filip Janku, M.D.,PhD
  • Chief Medical Officer
  • 1.26M
  • Edmund Dunn
  • Principal Accounting Officer, Senior Vice President and Corporate Controller
  • --
  • Dr. Andrew N. Schiff, M.D.
  • Non-Executive Chairman of the Board
  • 164.83K
  • Christine Siu
  • Independent Director
  • 124.02K
  • Dr. Kimberly L. Blackwell, M.D.
  • Independent Director
  • 123.39K
  • Dr. Jan Skvarka, M.B.A.,PhD
  • Independent Director
  • 111.44K
  • Dr. Eric A Hughes, M.D.,PhD
  • Independent Director
  • 281.36K
  • Dr. Chandra P. Leo, M.D.
  • Independent Director
  • --
  • Dr. Anthony M. Manning, PhD
  • Independent Director
  • 112.50K
  • Dr. Ali Behbahani, M.B.A.,M.D.
  • Independent Director
  • 117.77K

Market Insights

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More